$15.65
-0.01[-0.06%]
At close: Apr 25
$15.65
0[0.00%]
After Hours: 9:20AM EDT
Zai Lab
(NASDAQ:ZLAB)Latest News for Zai Lab Stock (NASDAQ:ZLAB)
Zai Lab Stock (NASDAQ: ZLAB)
Categories: All
Monday, April 01, 2024
Thursday, March 14, 2024
Wednesday, March 06, 2024
Thursday, February 29, 2024
Tuesday, February 27, 2024
Friday, February 09, 2024
Thursday, February 08, 2024
Monday, January 22, 2024
Wednesday, January 10, 2024
Thursday, December 21, 2023
Thursday, December 14, 2023
Wednesday, December 13, 2023
- Zai Lab shares are trading higher after the company announced VYVGART, NUZYRA and ZEJULA were added to China's 2023 National Reimbursement Drug List.Benzinga Newsdesk - Dec 13, 2023, 10:49AM
- Zai Lab Earlier Announced That The 2023 National Reimbursement Drug List Released By China's National Healthcare Security Administration Has Been Updated To Include VYVGART, NUZYRA And ZEJULABenzinga Newsdesk - Dec 13, 2023, 8:56AM
- Zai Lab Announces Inclusion Of VYVGART And Other Medicines In China's 2023 National Reimbursement Drug ListBenzinga Newsdesk - Dec 13, 2023, 1:54AM
Monday, December 11, 2023
Thursday, November 30, 2023
Wednesday, November 08, 2023
Tuesday, November 07, 2023
Monday, November 06, 2023
Monday, October 30, 2023
Thursday, October 26, 2023
- Zai Lab Limited shares are trading lower after Citigroup and Goldman Sachs maintained a Buy rating on the stock and lowered their respective price targets.Benzinga Newsdesk - Oct 26, 2023, 1:26PM
- Goldman Sachs Maintains Buy Rating for Zai Lab: Here's What You Need To KnowBenzinga Insights - Oct 26, 2023, 1:00PM
- Citigroup Maintains Buy on Zai Lab, Lowers Price Target to $128Benzinga Newsdesk - Oct 26, 2023, 10:36AM
- Goldman Sachs Maintains Buy on Zai Lab, Lowers Price Target to $73.34Benzinga Newsdesk - Oct 26, 2023, 10:12AM
Tuesday, October 24, 2023
Tuesday, October 17, 2023
Monday, October 09, 2023
Monday, September 18, 2023
- Cantor Fitzgerald Reiterates Overweight on Zai Lab, Maintains $70 Price TargetBenzinga Newsdesk - Sep 18, 2023, 11:59AM
- Zai Lab shares are trading higher after the company obtained Breakthrough Therapy Designation for efgartigimod alfa injection in China.Benzinga Newsdesk - Sep 18, 2023, 10:27AM
- Zai Lab Obtains Breakthrough Therapy Designation For Efgartigimod Alfa Injection In Patients With Chronic Inflammatory Demyelinating Polyneuropathy In ChinaBenzinga Newsdesk - Sep 18, 2023, 7:32AM
Tuesday, September 05, 2023
- Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Sep 5, 2023, 1:34PM
- Zai Lab shares are trading higher after the company last week received Breakthrough Therapy Designation for investigational repotrectinib in China.Benzinga Newsdesk - Sep 5, 2023, 12:30PM
- Brady, Airbnb, Insmed And Other Big Stocks Moving Higher On TuesdayLisa Levin - Sep 5, 2023, 10:43AM
- Encouraging Data From Seagen/Genmab's Cervical Cancer Study - Tivdak Success Sets Stage For New IndicationsVandana Singh - Sep 5, 2023, 8:53AM
Wednesday, August 30, 2023
- Zai Lab shares are trading higher after the company received Breakthrough Therapy Designation for investigational repotrectinib in China.Benzinga Newsdesk - Aug 30, 2023, 12:09PM
- Center For Drug Evaluation Of National Medical Products Administration Granted Breakthrough Therapy Designation For Zai Lab's Repotrectinib For Advanced Solid Tumors With NTRK Gene Fusion Who Have Progressed After TRK Tyrosine Kinase Inhibitor TreatmentBenzinga Newsdesk - Aug 30, 2023, 7:39AM